Prohibitin 1 is an evolutionary conserved and ubiquitously expressed protein that exerts different biological functions depending on its subcellular localization. The role of prohibitin 1 in liver cancer is controversial as it can be pro- or anti-tumorigenic. However, most of the studies to date have described prohibitin 1 primarily as a tumor suppressor in the liver. Its deficiency sensitizes the liver to cholestatic liver injury, non-alcoholic fatty liver disease, inflammatory insults, and cancer. Liver-specific Phb1-knockout mice spontaneously develop hepatocellular carcinoma, Phb1 heterozygotes are more susceptible to develop cholangiocarcinoma, and the majority of human hepatocellular carcinomas and cholangiocarcinomas have reduced prohibitin 1 expression. Consistent with a tumor suppressive role in the liver, prohibitin 1 negatively regulates proliferation in hepatocytes and human hepatocellular carcinoma and cholangiocarcinoma cell lines, and multiple oncogenic signaling pathways are activated when prohibitin 1 is deficient. Although best known as a mitochondrial chaperone, prohibitin 1 can protect the liver by mitochondrial-independent mechanisms. This review summarizes what’s known about prohibitin 1’s role in liver pathology, with the focus on hepatoprotection and carcinogenesis.
Impact statement
This review summarizes the last decades of research on PHB1 in liver pathobiology. PHB1 is a key player for liver health as it is hepatoprotective and tumor suppressive. We highlight the importance of PHB1’s subcellular localization, post-translational modifications, and interacting proteins as major determinants of PHB1 cytoprotective function and anti-tumor activity in the liver.
ThuaudFRibeiroNNebigilCGDésaubryL.Prohibitin ligands in cell death and survival: mode of action and therapeutic potential. Chem Biol2013;
20:316–31
2.
PengYTChenPOuyangRYSongL.Multifaceted role of prohibitin in cell survival and apoptosis. Apoptosis Int Apoptosis2015;
20:1135–49
3.
McClungJKDannerDBStewartDASmithJRSchneiderELLumpkinCKDell’OrcoRTNuellMJ.Isolation of a cDNA that hybrid selects antiproliferative mRNA from rat liver. Biochem Biophys Res Commun1989;
164:1316–22
4.
KoKSTomasiMLIglesias-AraAFrenchBAFrenchSWRamaniKLozanoJJOhPHeLStilesBLLiTWHYangHMartínez-ChantarMLMatoJMLuSC.Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice. Hepatology2010;
52:2096–108
5.
Sánchez-QuilesVSeguraVBigaudEHeBO’MalleyBWSantamaríaEPrietoJCorralesFJ.Prohibitin-1 deficiency promotes inflammation and increases sensitivity to liver injury. J Proteomics2012;
75:5783–92
6.
Barbier-TorresLBerazaNFernández-TussyPLopitz-OtsoaFFernández-RamosDZubiete-FrancoIVarela-ReyMDelgadoTCGutiérrezVAnguitaJParesABanalesJMVillaECaballeríaJAlvarezLLuSCMatoJMMartínez-ChantarML.Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1. Hepatology2015;
62:1237–48
7.
FanWYangHLiuTWangJLiTWHMavilaNTangYYangJPengHTuJAnnamalaiANoureddinMKrishnanAGoresGJMartínez-ChantarMLMatoJMLuSC.Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells. Hepatology2017;
65:1249–66
8.
MavilaNTangYBerlindJRamaniKWangJMatoJMLuSC.Prohibitin 1 acts as a negative regulator of wingless/Integrated-Beta-Catenin signaling in murine liver and human liver cancer cells. Hepatol Commun2018;
2:1583–600
9.
YangJWMurrayBBarbier-TorresLLiuTLiuZYangHFanWWangJLiYSekiEMatoJMLuSC.The mitochondrial chaperone prohibitin 1 negatively regulates interleukin-8 in human liver cancers. J Biol Chem2019;
294:1984–96
10.
MishraSMurphyLCMurphyLJ.The prohibitins: emerging roles in diverse functions. J Cell Mol Med2006;
10:353–63
11.
WinterAKämäräinenOHofmannA.Molecular modeling of prohibitin domains. Proteins2007;
68:353–62
12.
RastogiSJoshiBFusaroGChellappanS.Camptothecin induces nuclear export of prohibitin preferentially in transformed cells through a CRM-1-dependent mechanism. J Biol Chem2006;
281:2951–9
13.
AndeSRMishraS.Palmitoylation of prohibitin at cysteine 69 facilitates its membrane translocation and interaction with eps 15 homology domain protein 2 (EHD2). Biochem Cell Biol Biochim Biol2010;
88:553–8
14.
LeeJHNguyenKHMishraSNyombaB.Prohibitin is expressed in pancreatic beta-cells and protects against oxidative and proapoptotic effects of ethanol. FEBS J2010;
277:488–500
15.
DongPJiangLLiuJWuZGuoSZhangZZhouFLiuZ.Induction of paclitaxel resistance by ERα mediated prohibitin mitochondrial-nuclear shuttling. PLoS One2013;
8:e83519
16.
MengwasserJPiauASchlagPSleemanJP.Differential immunization identifies PHB1/PHB2 as blood-borne tumor antigens. Oncogene2004;
23:7430–5
17.
VessalMMishraSMoulikSMurphyLJ.Prohibitin attenuates insulin-stimulated glucose and fatty acid oxidation in adipose tissue by inhibition of pyruvate carboxylase. FEBS J2006;
273:568–76
18.
NijtmansLGde JongLArtal SanzMCoatesPJBerdenJABackJWMuijsersAOvan der SpekHGrivellLA.Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J2000;
19:2444–51
19.
CoatesPJJamiesonDJSmartKPrescottARHallPA.The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr Biol CB1997;
7:607–10
20.
NijtmansLGJArtalSMGrivellLACoatesPJ.The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease. Cell Mol Life Sci CMLS2002;
59:143–55
21.
TheissALSitaramanSV.The role and therapeutic potential of prohibitin in disease. Biochim Biophys Acta2011;
1813:1137–43
22.
LiuXRenZZhanRWangXWangXZhangZLengXYangZQianL.Prohibitin protects against oxidative stress-induced cell injury in cultured neonatal cardiomyocyte. Cell Stress Chaperones2009;
14:311–9
23.
GertzMFischerFWoltersDSteegbornC.Activation of the lifespan regulator p66Shc through reversible disulfide bond formation. Proc Natl Acad Sci USA2008;
105:5705–9
24.
Martínez-ChantarMLCorralesFJMartínez-CruzLAGarcía-TrevijanoERHuangZ-ZChenLKanelGAvilaMAMatoJMLuSC.Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J2002;
16:1292–4
25.
MerkwirthCDargazanliSTatsutaTGeimerSLöwerBWunderlichFTvon Kleist-RetzowJCWaismanAWestermannBLangerT.Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev2008;
22:476–88
26.
LiLMartin-LevilainJJiménez-SánchezCKaracaMFotiMMartinouJCMaechlerP.In vivo stabilization of OPA1 in hepatocytes potentiates mitochondrial respiration and gluconeogenesis in a prohibitin-dependent way. J Biol Chem2019;
294:12581–98
27.
JiangLDongPZhangZLiCLiYLiaoYLiXWuZGuoSMaiSXieDLiuZZhouF.Akt phosphorylates prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cells. Cell Death Dis2015;
6:e1660
28.
LiuYHPeckKLinJY.Involvement of prohibitin upregulation in Abrin-triggered apoptosis. Evid Based Complement Alternat Med2012;
2012:605154
29.
PengXMehtaRWangSChellappanSMehtaRG.Prohibitin is a novel target gene of vitamin D involved in its antiproliferative action in breast cancer cells. Cancer Res2006;
66:7361–9
30.
DartDASpencer-DeneBGambleSCWaxmanJBevanCL.Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours. Endocr Relat Cancer2009;
16:1157–69
31.
MishraSMurphyLCNyombaBLGMurphyLJ.Prohibitin: a potential target for new therapeutics. Trends Mol Med2005;
11:192–7
32.
WangSNathNAdlamMChellappanS.Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene1999;
18:3501–10
33.
WangSFusaroGPadmanabhanJChellappanSP.Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. Oncogene2002;
21:8388–96
34.
FusaroGDasguptaPRastogiSJoshiBChellappanS.Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J Biol Chem2003;
278:47853–61
35.
JupeERLiuXTKiehlbauchJLMcClungJKDell’OrcoRT.The 3’ untranslated region of prohibitin and cellular immortalization. Exp Cell Res1996;
224:128–35
36.
ManjeshwarSBranamDELernerMRBrackettDJJupeER.Tumor suppression by the prohibitin gene 3’untranslated region RNA in human breast cancer. Cancer Res2003;
63:5251–6
37.
YangHLiTWHZhouYPengHLiuTZandiEMartínez-ChantarMLMatoJMLuSC.Activation of a novel c-Myc-miR27-Prohibitin 1 circuitry in cholestatic liver injury inhibits glutathione synthesis in mice. Antioxid Redox Signal2015;
22:259–74
38.
RamaniKMavilaNKoKSMatoJMLuSC.Prohibitin 1 regulates the H19-Igf2 axis and proliferation in hepatocytes. J Biol Chem2016;
291:24148–59
39.
RajalingamKWunderCBrinkmannVChurinYHekmanMSieversCRappURRudelT.Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat Cell Biol2005;
7:837–43
40.
LuanZHeYAlattarMChenZHeF.Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma. Mol Cancer2014;
13:38
41.
PanTLWangPW.Explore the molecular mechanism of apoptosis induced by tanshinone IIA on activated rat hepatic stellate cells. Evid Based Complement Altern Med ECAM2012;
2012:734987
42.
SharmaAQadriA.Vi polysaccharide of salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses. Proc Natl Acad Sci USA2004;
101:17492–7
43.
WintachaiPWikanNKuadkitkanAJaimipukTUbolSPulmanausahakulRAuewarakulPKasinrerkWWengWYPanyasrivanitMPaemaneeAKittisenachaiSRoytrakulSSmithDR.Identification of prohibitin as a chikungunya virus receptor protein. J Med Virol2012;
84:1757–70
44.
KuadkitkanAWikanNFongsaranCSmithDR.Identification and characterization of prohibitin as a receptor protein mediating DENV-2 entry into insect cells. Virology2010;
406:149–61
45.
LiuSWangWBrownLEQiuCLajkiewiczNZhaoTZhouJPorcoJAWangTT.A novel class of small molecule compounds that inhibit hepatitis C virus infection by targeting the prohibitin-CRaf pathway. EBioMedicine2015;
2:1600–6
46.
KoloninMGSahaPKChanLPasqualiniRArapW.Reversal of obesity by targeted ablation of adipose tissue. Nat Med2004;
10:625–32
47.
HossenMNKajimotoKAkitaHHyodoMIshitsukaTHarashimaH.Therapeutic assessment of cytochrome C for the prevention of obesity through endothelial cell-targeted nanoparticulate system. Mol Ther J Ther2013;
21:533–41
48.
MenssenAHermekingH.Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc Natl Acad Sci USA2002;
99:6274–9
49.
PuppinCPassonNFranzoniARussoDDamanteG.Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells. Oncol Rep2011;
25:393–7
Schmidt-ArrasDRose-JohnS.IL-6 pathway in the liver: from physiopathology to therapy. J Hepatol2016;
64:1403–15
52.
QianXZhaoPLiWShiZ-MWangLXuQWangMLiuNLiuLZJiangBH.MicroRNA-26a promotes tumor growth and angiogenesis in glioma by directly targeting prohibitin. CNS Neurosci Ther2013;
19:804–12
53.
FletcherCEDartDASita-LumsdenAChengHRenniePSBevanCL.Androgen-regulated processing of the oncomir miR-27a, which targets prohibitin in prostate cancer. Hum Mol Genet2012;
21:3112–27
54.
LiuTTangHLangYLiuMLiX.MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett2009;
273:233–42
55.
ChenWQiJBaoGWangTDuCWWangMD.Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin. Mol Med Rep2015;
12:1515–23
56.
CiriloPDRde Sousa AndradeLNCorrêaBRSQiaoMFuruyaTKChammasRPenalvaL.MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting prohibitin 1. BMC Cancer2017;
17:750
57.
LiJAungLHHLongBQinDAnSLiP.miR-23a binds to p53 and enhances its association with miR-128 promoter. Sci Rep2015;
5:16422
58.
FengFQiuBZangRSongPGaoS.Pseudogene PHBP1 promotes esophageal squamous cell carcinoma proliferation by increasing its cognate gene PHB expression. Oncotarget2017;
8:29091–100
59.
HanEKMcgonigalTButlerCGirandaVLLuoY.Characterization of Akt overexpression in MiaPaCa-2 cells: prohibitin is an Akt substrate both in vitro and in cells. Anticancer Res2008;
28:957–63
60.
AndeSRGuYNyombaBLGMishraS.Insulin induced phosphorylation of prohibitin at tyrosine 114 recruits Shp1. Biochim Biophys Acta2009;
1793:1372–8
61.
AndeSRMoulikSMishraS.Interaction between O-GlcNAc modification and tyrosine phosphorylation of prohibitin: implication for a novel binary switch. PLoS One2009;
4:e4586
62.
ThompsonWERamalho-SantosJSutovskyP.Ubiquitination of prohibitin in mammalian sperm mitochondria: possible roles in the regulation of mitochondrial inheritance and sperm quality control. Biol Reprod2003;
69:254–60
63.
SuhSKHoodBLKimBJConradsTPVeenstraTDSongBJ.Identification of oxidized mitochondrial proteins in alcohol-exposed human hepatoma cells and mouse liver. Proteomics2004;
4:3401–12
64.
AndeSRMishraS.Prohibitin interacts with phosphatidylinositol 3,4,5-triphosphate (PIP3) and modulates insulin signaling. Biochem Biophys Res Commun2009;
390:1023–8
65.
ChiuCFHoMYPengJMHungSWLeeWHLiangCMLiangSM.Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane. Oncogene2013;
32:777–87
66.
MishraSAndeSRNyombaB.The role of prohibitin in cell signaling. FEBS J2010;
277:3937–46
67.
SantamariaEAvilaMALatasaMURubioAMartin-DuceALuSCCorralesFJ.Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc Natl Acad Sci USA2003;
100:3065–70
68.
LuSCMatoJM.S-adenosylmethionine in liver health, injury, and cancer. Physiol Rev2012;
92:1515–42
69.
MurrayBBarbier-TorresLFanWMatoJMLuSC.Methionine adenosyltransferases in liver cancer. World J Gastroenterol2019;
25:4300–19
70.
YangHLiuTWangJLiTWHFanWPengHKrishnanAGoresGJMatoJMLuSC.Deregulated methionine adenosyltransferase α1, c-Myc, and Maf proteins together promote cholangiocarcinoma growth in mice and humans(‡). Hepatology2016;
64:439–55
71.
ChowdhuryIThompsonWEThomasK.Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway. J Cell Physiol2014;
229:998–1004
72.
YangJLiBHeQY.Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment. Cell Death Dis2018;
9:580
73.
Sánchez-QuilesVSantamaríaESeguraVSesmaLPrietoJCorralesFJ.Prohibitin deficiency blocks proliferation and induces apoptosis in human hepatoma cells: molecular mechanisms and functional implications. Proteomics2010;
10:1609–20
74.
MongaSP.β-Catenin signaling and roles in liver homeostasis, injury, and tumorigenesis. Gastroenterology2015;
148:1294–310
75.
Nejak-BowenKNMongaS.Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol2011;
21:44–58
76.
TheissALJenkinsAKOkoroNIKlapprothJ-MMerlinDSitaramanSV.Prohibitin inhibits tumor necrosis factor alpha–induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin α3 expression. Mol Biol Cell2009;
20:4412–23
77.
LueddeTSchwabeRF.NF-κB in the liver–linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol2011;
8:108–18
78.
ShimizuYOkadaKTsukishiroTNishimoriHHiguchiKWatanabeA.Cytokine effect on the concentrations of interleukin-8 (IL-8) in the culture medium of human liver tumor cell lines. Int Hepatol Commun1993;
1:174–7
79.
OkadaKShimizuYTsukishiroTMinemuraMNishimoriHHiguchiKWatanabeA.Serum interleukin-8 levels in patients with hepatocellular carcinoma. Int Hepatol Commun1994;
2:178–82
80.
AkibaJYanoHOgasawaraSHigakiKKojiroM.Expression and function of interleukin-8 in human hepatocellular carcinoma. Int J Oncol2001;
18:257–64
81.
MiyamotoMShimizuYOkadaKKashiiYHiguchiKWatanabeA.Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells. Cancer Immunol Immunother CII1998;
47:47–57
